Stakeholder groups approached the Division of Financial Regulation about the use of Medicare-approved amount caps and Medicare enrollment for end stage renal disease (ESRD) patients in the commercial health benefit plan market. In an effort to collect more information on the topic, the division solicited public comment during a public meeting on Friday, Oct. 23, 2015, and via email through 5 p.m. Tuesday, Oct. 27, 2015. Eighteen individuals testified during the Oct. 23 meeting and more than 30 written comments were submitted to the division. The division also completed an insurer data call targeting the six commercial health benefit plan insurers with ESRD specific benefit language in member handbooks.
Below are three documents the division prepared relating to kidney dialysis or ESRD benefits in commercial health benefit plans: